Featured Research

from universities, journals, and other organizations

Statin Drugs Lower Heart Disease Risk In Postmenopausal Women

Date:
June 4, 2002
Source:
American Heart Association
Summary:
Treatment with a cholesterol-lowering statin can significantly reduce the risk of heart disease and possibly death in postmenopausal women taking hormone replacement therapy (HRT), investigators report in Circulation: Journal of the American Heart Association.

DALLAS, June 4 – Treatment with a cholesterol-lowering statin can significantly reduce the risk of heart disease and possibly death in postmenopausal women taking hormone replacement therapy (HRT), investigators report in the rapid access issue of Circulation: Journal of the American Heart Association.

Women taking statins had a 21 percent lower risk of heart attack and death related to heart disease and a 33 percent lower risk of dying from any cause during four years of treatment, compared to women who did not take statins. Statin therapy was also associated with a 55 percent lower risk of venous thromboembolism (VTE, blood clots in veins), a potentially life-threatening problem that can occur in women on HRT.

"These data add substantial additional support for use of statins in women with heart disease," says David Herrington, M.D., M.H.S., lead author of the report. "Our results help clarify residual concerns about the true magnitude of statins' benefit in women, because three previous clinical trials had produced somewhat divergent results."

Herrington's team reviewed data from the Heart and Estrogen/progestin Replacement Study (HERS). The primary purpose of HERS was to evaluate the effect of HRT on heart attack and death in 2,763 women with coronary heart disease. The principal finding of HERS showed no overall effect of hormone replacement therapy on coronary risk.

In their reanalysis of HERS data, researchers looked specifically at the outcomes of 1,004 women taking a statin drug when they entered the study, as well as 708 who began statin therapy during the trial. They found that women taking statins at baseline or at any time during the trial had significantly fewer first-time coronary heart disease (CHD) events (heart attack or CHD death) than those who did not take statins.

Women in HERS who took a statin for at least three years had a 26 percent lower rate of heart attack and coronary death. Statin use for less than three years was associated with a more modest 11 percent risk reduction, compared to non-statin users. Death from any cause was 30 percent lower in women who used a statin at any time during the HERS trial.

Statin drugs have a well-established ability to reduce heart disease risk in men, but until recently the effects in women were less clear, says Herrington, a professor of medicine at Wake Forest University in Winston-Salem, N.C. Earlier studies of statin therapy included relatively few women, and the benefits in women varied widely. HERS was unique because of the large number of women available for study. (Subsequent to HERS, a preliminary summary from the large Heart Protection Study reported significant risk reductions for CHD in women taking 40 mg/day of simvastatin.)

Herrington wanted to reexamine the HERS data to clarify the effects of statins on cardiovascular events in women and to examine the combined effects of statins and HRT on heart attack deaths in postmenopausal women.

Mirroring the primary findings of the HERS trial, the statin analysis showed that HRT users who were not taking a statin had an especially high risk for coronary events during the first year of the trial – 75 percent higher compared to the placebo group. In contrast, women who were on HRT and a statin during the first year of HERS had the same risk of CHD events as the placebo group.

"The data suggest that statins might help diminish the adverse effects of HRT, but the finding needs to be confirmed in other studies," says Herrington.

Some scientists have wondered whether the lack of HRT benefit on coronary risk in HERS was because of increased statin use in the placebo group, Herrington says. To evaluate the impact of increased statin use in the placebo group, the researchers reanalyzed the data after excluding both women who started statin therapy during HERS and women who took statins before and during the trial. After statistically adjusting for an imbalance in statin use between the treatment and placebo groups, they still did not find a benefit for HRT.

"This study shows that increased statin use in the placebo group did not explain the null finding of the HERS trial," says Herrington.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Statin Drugs Lower Heart Disease Risk In Postmenopausal Women." ScienceDaily. ScienceDaily, 4 June 2002. <www.sciencedaily.com/releases/2002/06/020604073833.htm>.
American Heart Association. (2002, June 4). Statin Drugs Lower Heart Disease Risk In Postmenopausal Women. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2002/06/020604073833.htm
American Heart Association. "Statin Drugs Lower Heart Disease Risk In Postmenopausal Women." ScienceDaily. www.sciencedaily.com/releases/2002/06/020604073833.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com
West Africa Gripped by Deadly Ebola Outbreak

West Africa Gripped by Deadly Ebola Outbreak

AFP (July 28, 2014) The worst-ever outbreak of the deadly Ebola epidemic grips west Africa, killing hundreds. Duration: 00:48 Video provided by AFP
Powered by NewsLook.com
Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins